Kepler Cheuvreux Suisse SA lessened its position in shares of Stryker Corporation (NYSE:SYK – Free Report) by 95.8% in the 4th quarter, HoldingsChannel reports. The fund owned 3,201 shares of the medical technology company’s stock after selling 72,420 shares during the period. Kepler Cheuvreux Suisse SA’s holdings in Stryker were worth $1,125,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Drive Wealth Management LLC grew its stake in Stryker by 24.0% during the 4th quarter. Drive Wealth Management LLC now owns 702 shares of the medical technology company’s stock worth $247,000 after buying an additional 136 shares during the last quarter. Osprey Private Wealth LLC purchased a new stake in Stryker in the fourth quarter valued at about $246,000. Income Insurance Ltd purchased a new stake in Stryker in the fourth quarter valued at about $361,000. Bryn Mawr Trust Advisors LLC raised its stake in Stryker by 7.3% in the fourth quarter. Bryn Mawr Trust Advisors LLC now owns 3,680 shares of the medical technology company’s stock valued at $1,293,000 after buying an additional 249 shares during the last quarter. Finally, Advisor OS LLC raised its stake in Stryker by 95.6% in the fourth quarter. Advisor OS LLC now owns 1,794 shares of the medical technology company’s stock valued at $630,000 after buying an additional 877 shares during the last quarter. Hedge funds and other institutional investors own 77.09% of the company’s stock.
Wall Street Analyst Weigh In
A number of research firms have commented on SYK. Leerink Partners began coverage on Stryker in a research note on Monday, April 13th. They issued an “outperform” rating and a $410.00 price target for the company. Deutsche Bank Aktiengesellschaft set a $315.00 price target on Stryker in a research note on Friday, May 1st. Citigroup decreased their price target on Stryker from $420.00 to $385.00 and set a “buy” rating for the company in a research note on Tuesday, April 7th. Canaccord Genuity Group decreased their price target on Stryker from $435.00 to $400.00 and set a “buy” rating for the company in a research note on Friday, May 1st. Finally, William Blair reiterated an “outperform” rating on shares of Stryker in a research note on Thursday, March 5th. Sixteen investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $395.48.
Stryker Stock Performance
Shares of SYK opened at $282.85 on Tuesday. The stock has a 50-day moving average of $336.33 and a two-hundred day moving average of $353.81. Stryker Corporation has a one year low of $281.00 and a one year high of $404.87. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.25 and a current ratio of 2.11. The stock has a market cap of $108.33 billion, a P/E ratio of 32.74, a P/E/G ratio of 1.80 and a beta of 0.80.
Stryker (NYSE:SYK – Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The medical technology company reported $2.60 EPS for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). Stryker had a return on equity of 23.42% and a net margin of 13.20%.The firm had revenue of $6.02 billion for the quarter, compared to analyst estimates of $6.34 billion. During the same period in the prior year, the firm posted $2.84 EPS. The business’s revenue was up 2.6% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. As a group, research analysts predict that Stryker Corporation will post 14.98 EPS for the current year.
Stryker Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be given a dividend of $0.88 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.52 dividend on an annualized basis and a yield of 1.2%. Stryker’s payout ratio is currently 40.74%.
About Stryker
Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.
Featured Stories
- Five stocks we like better than Stryker
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK – Free Report).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.
